{"nct_id":"NCT01663766","title":"Phase I Study of Milatuzumab for Graft Versus Host Disease","status":"TERMINATED","status_verified_date":"2020-09","start_date":"2013-12","start_date_type":"ACTUAL","primary_completion_date":"2015-03","primary_completion_date_type":"ACTUAL","completion_date":"2015-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}